Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Camber Capital Management is a Boston-based hedge fund founded in 2006 by Stephen DuBois. The firm specializes in long/short equity strategies with a strong focus on the healthcare sector, including pharmaceutical, biotech, medical device, and healthcare services companies. As of early 2025, it manages approximately $2.8–$4.3 billion in assets and holds significant positions in major public healthcare companies such as Pfizer, Humana, Zimmer Biomet Holdings, Baxter International, and others.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Camber Capital Management.